

Z03467 · 100 ug10 mgml
GenScript · Cat: Z03467
Reach 3+ verified distributors
Manufacturer product page
genscript.com/protein/Z03467-GenCrispr_NLS_Cas9_EGFP_Nucleas...
Description
GenCrispr NLS-Cas9-EGFP is a fusion protein developed by GenScript. It contains a nuclear localization sequence NLS on its N terminal and EGFP on the C terminal. Cas9 nuclease is an RNA-guided endonuclease that can catalyze cleavage of double stranded DNA. This kind of targeted nuclease is a powerful tool for genome editing with high precision. Cas9 protein forms a very stable ribonucleoprotein RNP complex with the guide RNA gRNA component of the CRISPR/Cas9 system. The Cas9 RNP complex can localize to the nucleus immediately upon entering the cell with the addition of a nuclear localization signal NLS . There is no requirement for transcription and translation compared with mRNA or plasmid systems. Additionally, the Cas9 RNP complex is rapidly cleared from the cells minimizing the chance of off-target cleavage when compared to other systems Kim, et al. 2014 . The EGFP can be used as a reporter for tracking or sorting transfected cells, which enables the possibility of enriching cell populations for desired genome edits via fluorescence activated cell sorting FACS . It significantly reduces the labor and cost associated with single cell cloning and genotyping in genome editing applications.
![VEGF R2/KDR[Biotin], His&Avi, Human](https://biomall.ai/api/proxy-image?url=https%3A%2F%2Fwww.genscript.com%2Fproduct%2Fdocuments%2Fdown%3Fdoc_name%3DZ03970%2520HPLC.png%26file%3Dscm_files%2FproductFile_notes%2F2025%2F03%2F12%2FZ03970%2520HPLC.png)






